TY - JOUR
T1 - Dexamethasone Addition to Popliteal Nerve Blocks
T2 - Effects on Duration of Analgesia and Incidence of Postoperative Nerve Complication
AU - Noori, Naudereh
AU - Anand, Kapil
AU - Pfeffer, Glenn
AU - Thordarson, David
N1 - Publisher Copyright:
© 2020 The Author(s).
PY - 2021/2
Y1 - 2021/2
N2 - Background. The purpose of this prospective, double-blinded randomized control pilot study was to evaluate the effect of adjunctive dexamethasone on analgesia duration and the incidence of postoperative neuropathic complication. Peripheral nerve blocks are an effective adjunct to decrease postoperative pain in foot and ankle surgery, and any possible modalities to augment their efficacy is of clinical utility. Methods. Patients were randomly assigned to a control group (n = 25) receiving nerve blocks of bupivacaine and epinephrine or an experimental group (n = 24) with an adjunctive 8 mg dexamethasone. The patients, surgeons, and anesthesiologists were all blinded to allocation. Patients had a minimum 1 year postoperative follow-up. Results. Forty-nine patients completed the protocol. There was no statistically significant difference in analgesia duration (P =.38) or postoperative neuropathic complication incidence (P =.67) between the 2 groups. Conclusions. The addition of dexamethasone to popliteal nerve blocks does not appear to affect analgesia duration or incidence of postoperative neuropathic complications. However, our study was underpowered, and we recommend a larger scale prospective study for validation. Levels of Evidence: Level II: Prospective, randomized control pilot study
AB - Background. The purpose of this prospective, double-blinded randomized control pilot study was to evaluate the effect of adjunctive dexamethasone on analgesia duration and the incidence of postoperative neuropathic complication. Peripheral nerve blocks are an effective adjunct to decrease postoperative pain in foot and ankle surgery, and any possible modalities to augment their efficacy is of clinical utility. Methods. Patients were randomly assigned to a control group (n = 25) receiving nerve blocks of bupivacaine and epinephrine or an experimental group (n = 24) with an adjunctive 8 mg dexamethasone. The patients, surgeons, and anesthesiologists were all blinded to allocation. Patients had a minimum 1 year postoperative follow-up. Results. Forty-nine patients completed the protocol. There was no statistically significant difference in analgesia duration (P =.38) or postoperative neuropathic complication incidence (P =.67) between the 2 groups. Conclusions. The addition of dexamethasone to popliteal nerve blocks does not appear to affect analgesia duration or incidence of postoperative neuropathic complications. However, our study was underpowered, and we recommend a larger scale prospective study for validation. Levels of Evidence: Level II: Prospective, randomized control pilot study
KW - dexamethasone
KW - pain
KW - popliteal nerve block
UR - http://www.scopus.com/inward/record.url?scp=85077635999&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077635999&partnerID=8YFLogxK
U2 - 10.1177/1938640019897224
DO - 10.1177/1938640019897224
M3 - Article
C2 - 31904292
AN - SCOPUS:85077635999
SN - 1938-6400
VL - 14
SP - 39
EP - 45
JO - Foot and Ankle Specialist
JF - Foot and Ankle Specialist
IS - 1
ER -